Accretion Pharma's board appointed two independent directors, bolstering oversight.

Statutory auditors were re-appointed, and an Executive Director was re-designated.

A new experienced Company Secretary was appointed following a resignation.

An Annual General Meeting is planned for shareholder approvals.